BRIEF published on 06/09/2026 at 22:05, 3 months 29 days ago Update on Inventiva's Share Capital and Voting Rights as of May 2026 Euronext Paris Share Capital Voting Rights Biopharmaceutical Inventiva
PRESS RELEASE published on 06/09/2026 at 22:00, 3 months 29 days ago Statement of Total Voting Rights and Shares Forming The Company’s Share Capital as of May 22, 2026 Inventiva reports total voting rights and shares forming the company's share capital as of May 22, 2026, in compliance with Article R. 22-10-23 of the French Commercial Code Euronext Paris Shares Total Voting Rights Inventiva MASH
BRIEF published on 06/08/2026 at 09:41, 4 months 1 day ago Sofinnova's threshold crossing in INVENTIVA Voting Rights Threshold Crossing New Actions Inventiva Sofinnova Partners
BRIEF published on 06/02/2026 at 14:35, 4 months 7 days ago Inventiva Resumes Trading on Euronext Paris Euronext Paris Debt Financing Trading Resumption Inventiva MASH Treatment
PRESS RELEASE published on 06/02/2026 at 14:30, 4 months 7 days ago Inventiva Announces Trading Resumption of its Ordinary Shares on Euronext Paris Inventiva announces trading resumption of its ordinary shares on Euronext Paris following Debt Financing Transaction and ADS Offering Euronext Paris Ordinary Shares Clinical-Stage Biopharmaceutical Trading Resumption Inventiva
BRIEF published on 06/02/2026 at 07:35, 4 months 7 days ago Temporary suspension of Inventiva shares on Euronext Paris Euronext Paris Funding Nasdaq Inventiva Temporary Suspension
BRIEF published on 06/02/2026 at 07:35, 4 months 7 days ago Inventiva Halts Trading of Ordinary Shares on Euronext Paris Euronext Paris Trading Halt Inventiva MASH Treatment Nadsaq
PRESS RELEASE published on 06/02/2026 at 07:30, 4 months 7 days ago Inventiva Announces Temporary Trading Halt of its Ordinary Shares on Euronext Paris Inventiva announces temporary trading halt of its ordinary shares on Euronext Paris for a proposed financing transaction. Trading to resume after communication Euronext Paris Trading Halt Clinical Trial Inventiva Metabolic Dysfunction
BRIEF published on 05/26/2026 at 22:05, 4 months 13 days ago Inventiva Announces its First Quarter 2026 Financial Results Financial Results Treasury Biopharmaceutical Inventiva NATiV3
PRESS RELEASE published on 05/26/2026 at 22:00, 4 months 13 days ago Inventiva Reports 2026 First Quarter Financial Information¹ Inventiva reports first quarter 2026 financial information, with cash and cash equivalents at €75.0 million and short-term deposits at €121.5 million. Explore company's financial results and upcoming milestones Financial Information Inventiva NATiV3 Cash Equivalents Short-term Deposits
Published on 10/09/2026 at 14:00, 4 hours 24 minutes ago Stillwater Critical Minerals Upgrades to OTCQX Best Market, Expanding U.S. Market Presence
Published on 10/09/2026 at 14:00, 4 hours 24 minutes ago Vogenx Appoints Board Member Richard Gorman as Chief Commercial Officer
Published on 10/09/2026 at 13:23, 5 hours 1 minute ago SLAM Exploration Announces Leadership Transition and Appointment of Jimmy Gravel as President and CEO
Published on 10/09/2026 at 13:00, 5 hours 24 minutes ago Horizon Aircraft Reports Fiscal 2027 First Quarter Results and Advances Full-Scale Cavorite X7 Development
Published on 10/09/2026 at 13:00, 5 hours 24 minutes ago Nepra Foods Launches Flagship PROPASTA Brand on Amazon
Published on 10/09/2026 at 18:00, 24 minutes ago ARVERNE GROUP: Arverne reaches a major milestone: Europe recognizes the Lithium de France Project as a pillar of its industrial sovereignty
Published on 10/09/2026 at 18:00, 24 minutes ago Private Equity Holding AG: Net Asset Value as of September 30, 2026
Published on 10/09/2026 at 17:15, 1 hour 9 minutes ago OPPO Find X10 Pro Max to Debut Globally with MediaTek’s 2nm Flagship Dimensity 9600 Pro
Published on 10/09/2026 at 17:10, 1 hour 14 minutes ago "Soaring Creativity - Hong Kong Pavilion" Returns to Frankfurt Book Fair 2026, Showcasing Over 1,000 Masterpieces
Published on 10/09/2026 at 16:30, 1 hour 54 minutes ago Novem Group S.A.: Changes in Management Board
Published on 10/08/2026 at 18:30, 23 hours 54 minutes ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 1 day ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 1 day ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
Published on 10/07/2026 at 18:19, 2 days ago Outstanding shares and voting rights statement at 30 September 2026
